BeOne Medicines (ONC) PT Raised to $425 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev raised the price target on BeOne Medicines (NASDAQ: ONC) to $425.00 (from $417.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
